Dr Claire Paterson
- Honorary Clinical Associate Professor (School of Cancer Sciences)
Publications
2025
Peters, A. L. et al. (2025) Involved neck only versus mucosal radiotherapy for head and neck squamous cell cancer of unknown primary (HNSCCUP): a national retrospective multicentre cohort study. International Journal of Radiation Oncology, Biology, Physics, (doi: 10.1016/j.ijrobp.2025.11.013) (Accepted for Publication)
Clements, Kelten, Hurley, Rhona, Conway, David I. ORCID: https://orcid.org/0000-0001-7762-4063, Paterson, Claire and Douglas, Catriona M.
(2025)
The changing profile of laryngeal cancer: a 20-year retrospective cohort analysis.
European Archives of Oto-Rhino-Laryngology, 282(9),
pp. 4795-4805.
(doi: 10.1007/s00405-025-09500-y)
(PMID:40517162)
Chmielecka, M. et al. (2025) Does Modified 5-Item Frailty Index correlate with survival in oropharyngeal squamous cell carcinoma? Head and Neck, (doi: 10.1002/hed.70005) (PMID:40781491) (Early Online Publication)
Creaney, G. et al. (2025) Advanced stage head and neck cancer diagnosis: HEADSpAcE Consortium health systems benchmarking survey. Head and Neck, 47(7), pp. 1977-1988. (doi: 10.1002/hed.28094) (PMID:39994901) (PMCID:PMC12146806)
Hurley, Rhona, Paterson, Claire, Conway, David I. ORCID: https://orcid.org/0000-0001-7762-4063, Inman, Gareth J.
ORCID: https://orcid.org/0000-0002-6264-4253 and Douglas, Catriona M.
(2025)
Laryngeal cancer in the West of Scotland 2014–2020: trends and survival in a cohort of 867 patients.
Laryngoscope, 135(6),
pp. 2051-2061.
(doi: 10.1002/lary.31992)
(PMID:39757891)
(PMCID:PMC12082022)
Clements, Kelten, McMahon, Alex D. ORCID: https://orcid.org/0000-0002-9425-7792, Bhatti, Lesley, Smith, Craig, Paterson, Claire, Douglas, Catriona M. and Conway, David
ORCID: https://orcid.org/0000-0001-7762-4063
(2025)
Incidence trends in head and neck cancer subsites: a national population-based study (2001-2020).
Clinical Otolaryngology, 50(3),
pp. 474-484.
(doi: 10.1111/coa.14271)
(PMID:39800346)
(PMCID:PMC11975201)
Hurley, Rhona, Osbourne, James, Inman, Gareth J. ORCID: https://orcid.org/0000-0002-6264-4253, Conway, David I.
ORCID: https://orcid.org/0000-0001-7762-4063, Paterson, Claire and Douglas, Catriona
(2025)
Pre-treatment serum prognostic scores and survival in curatively treated laryngeal cancer.
Laryngoscope Investigative Otolaryngology, 10(2),
e70124.
(doi: 10.1002/lio2.70124)
(PMID:40124253)
(PMCID:PMC11929121)
2024
Smith, Craig D.L., McMahon, Alex D. ORCID: https://orcid.org/0000-0002-9425-7792, Purkayastha, Mitana, Creaney, Grant
ORCID: https://orcid.org/0000-0001-9972-7629, Clements, Kelten, Inman, Gareth J.
ORCID: https://orcid.org/0000-0002-6264-4253, Bhatti, Lesley A., Douglas, Catriona M., Paterson, Claire and Conway, David I.
ORCID: https://orcid.org/0000-0001-7762-4063
(2024)
Head and neck cancer incidence is rising but the sociodemographic profile is unchanging: a population epidemiological study (2001-2020).
BJC Reports, 2,
71.
(doi: 10.1038/s44276-024-00089-z)
(PMID:39301277)
(PMCID:PMC11408244)
Clements, Kelten, Thapa, Alekh, Cowell, Anna, Conway, David ORCID: https://orcid.org/0000-0001-7762-4063, Douglas, Catriona M. and Paterson, Claire
(2024)
Impact of the COVID-19 pandemic on stage and incidence of head and neck cancer: a rapid review and meta-analysis.
Clinical Otolaryngology, 49(4),
pp. 363-375.
(doi: 10.1111/coa.14152)
(PMID:38514776)
Thapa, A. et al. (2024) The UK Divide: Does having a Pembrolizumab-Chemotherapy option in head and neck cancer matter? Real-world experience of first-line palliative pembrolizumab monotherapy and pembrolizumab-chemotherapy combination in Scotland. Clinical Oncology, 36(5), pp. 287-299. (doi: 10.1016/j.clon.2024.02.004) (PMID:38395634)
2023
Clements, Kelten, Cowell, Anna, White, Gillian, Flynn, Willian, Conway, David I. ORCID: https://orcid.org/0000-0001-7762-4063, Douglas, Catriona M. and Paterson, Claire
(2023)
The COVID-19 pandemic has not changed stage at presentation nor treatment patterns of head and neck cancer: a retrospective cohort study.
Clinical Otolaryngology, 48(4),
pp. 587-594.
(doi: 10.1111/coa.14048)
(PMID:36929626)
Hay, Lisa K., McLoone, Philip ORCID: https://orcid.org/0000-0003-0002-8700, Borgaonkar, Saurabh, Schipani, Stefano, Wilson, Christina, Grose, Derek, James, Allan
ORCID: https://orcid.org/0000-0003-4472-7095, Lamb, Carolynn and Paterson, Claire
(2023)
Can elderly patients be safely selected for head and neck radiotherapy without formal geriatric or frailty assessment: a retrospective cohort study.
Clinical Otolaryngology, 48(2),
pp. 240-244.
(doi: 10.1111/coa.14005)
(PMID:36366954)
Poon, Wai-Yan, Paterson, Claire, McLoone, Philip ORCID: https://orcid.org/0000-0003-0002-8700, Grose, Derek, Schipani, Stefano, Lamb, Carolynn, James, Allan
ORCID: https://orcid.org/0000-0003-4472-7095 and Wilson, Christina
(2023)
Survival outcomes in hypopharyngeal cancer in the West of Scotland Cancer Network.
Clinical Otolaryngology, 48(2),
pp. 235-239.
(doi: 10.1111/coa.14003)
(PMID:36344424)
2022
Creaney, Grant ORCID: https://orcid.org/0000-0001-9972-7629, McMahon, Alex D.
ORCID: https://orcid.org/0000-0002-9425-7792, Ross, Alastair J.
ORCID: https://orcid.org/0000-0003-2952-3182, Bhatti, Lesley A., Paterson, Claire and Conway, David I.
ORCID: https://orcid.org/0000-0001-7762-4063
(2022)
Head and neck cancer in the UK: what was the stage before COVID-19? UK cancer registries analysis (2011-2018).
British Dental Journal, 233(9),
pp. 787-793.
(doi: 10.1038/s41415-022-5151-4)
(PMID:36369569)
(PMCID:PMC9650177)
Zhou, S. et al. (2022) Long term survival in patients with human papillomavirus-positive oropharyngeal cancer and equivocal response on 12-week PET-CT is not compromised by the omission of neck dissection. Oral Oncology, 128, 105870. (doi: 10.1016/j.oraloncology.2022.105870) (PMID:35447564)
Grocutt, Laura, Paterson, Claire and Valentine, Ronan M. (2022) Adaptive dose escalated radiotherapy in oropharyngeal cancers: a treatment planning feasibility study. Radiation Oncology, 17, 24. (doi: 10.1186/s13014-022-01991-x) (PMID:35123516) (PMCID:PMC8817487)
2020
Poon, W.-Y. et al. (2020) Comparative cohort study of volumetric modulated arc therapy for squamous cell cancer of unknown primary in the head and neck-involved neck only versus mucosal irradiation. Clinical Otolaryngology, 45(6), pp. 847-852. (doi: 10.1111/coa.13593) (PMID:32501648)
Hay, L. K. et al. (2020) Analysis of dose using CBCT and synthetic CT during head and neck radiotherapy: A single centre feasibility study. Technical Innovations and Patient Support in Radiation Oncology, 14, pp. 21-29. (doi: 10.1016/j.tipsro.2020.02.004) (PMID:32226833) (PMCID:PMC7093804)
2019
Paterson, C. et al. (2019) Radiotherapy-induced xerostomia: a randomised, double-blind, controlled trial of Visco-ease™ oral spray compared with placebo in patients with cancer of the head and neck. British Journal of Oral and Maxillofacial Surgery, 57(10), pp. 1119-1125. (doi: 10.1016/j.bjoms.2019.10.300) (PMID:31672256)
Articles
Peters, A. L. et al. (2025) Involved neck only versus mucosal radiotherapy for head and neck squamous cell cancer of unknown primary (HNSCCUP): a national retrospective multicentre cohort study. International Journal of Radiation Oncology, Biology, Physics, (doi: 10.1016/j.ijrobp.2025.11.013) (Accepted for Publication)
Clements, Kelten, Hurley, Rhona, Conway, David I. ORCID: https://orcid.org/0000-0001-7762-4063, Paterson, Claire and Douglas, Catriona M.
(2025)
The changing profile of laryngeal cancer: a 20-year retrospective cohort analysis.
European Archives of Oto-Rhino-Laryngology, 282(9),
pp. 4795-4805.
(doi: 10.1007/s00405-025-09500-y)
(PMID:40517162)
Chmielecka, M. et al. (2025) Does Modified 5-Item Frailty Index correlate with survival in oropharyngeal squamous cell carcinoma? Head and Neck, (doi: 10.1002/hed.70005) (PMID:40781491) (Early Online Publication)
Creaney, G. et al. (2025) Advanced stage head and neck cancer diagnosis: HEADSpAcE Consortium health systems benchmarking survey. Head and Neck, 47(7), pp. 1977-1988. (doi: 10.1002/hed.28094) (PMID:39994901) (PMCID:PMC12146806)
Hurley, Rhona, Paterson, Claire, Conway, David I. ORCID: https://orcid.org/0000-0001-7762-4063, Inman, Gareth J.
ORCID: https://orcid.org/0000-0002-6264-4253 and Douglas, Catriona M.
(2025)
Laryngeal cancer in the West of Scotland 2014–2020: trends and survival in a cohort of 867 patients.
Laryngoscope, 135(6),
pp. 2051-2061.
(doi: 10.1002/lary.31992)
(PMID:39757891)
(PMCID:PMC12082022)
Clements, Kelten, McMahon, Alex D. ORCID: https://orcid.org/0000-0002-9425-7792, Bhatti, Lesley, Smith, Craig, Paterson, Claire, Douglas, Catriona M. and Conway, David
ORCID: https://orcid.org/0000-0001-7762-4063
(2025)
Incidence trends in head and neck cancer subsites: a national population-based study (2001-2020).
Clinical Otolaryngology, 50(3),
pp. 474-484.
(doi: 10.1111/coa.14271)
(PMID:39800346)
(PMCID:PMC11975201)
Hurley, Rhona, Osbourne, James, Inman, Gareth J. ORCID: https://orcid.org/0000-0002-6264-4253, Conway, David I.
ORCID: https://orcid.org/0000-0001-7762-4063, Paterson, Claire and Douglas, Catriona
(2025)
Pre-treatment serum prognostic scores and survival in curatively treated laryngeal cancer.
Laryngoscope Investigative Otolaryngology, 10(2),
e70124.
(doi: 10.1002/lio2.70124)
(PMID:40124253)
(PMCID:PMC11929121)
Smith, Craig D.L., McMahon, Alex D. ORCID: https://orcid.org/0000-0002-9425-7792, Purkayastha, Mitana, Creaney, Grant
ORCID: https://orcid.org/0000-0001-9972-7629, Clements, Kelten, Inman, Gareth J.
ORCID: https://orcid.org/0000-0002-6264-4253, Bhatti, Lesley A., Douglas, Catriona M., Paterson, Claire and Conway, David I.
ORCID: https://orcid.org/0000-0001-7762-4063
(2024)
Head and neck cancer incidence is rising but the sociodemographic profile is unchanging: a population epidemiological study (2001-2020).
BJC Reports, 2,
71.
(doi: 10.1038/s44276-024-00089-z)
(PMID:39301277)
(PMCID:PMC11408244)
Clements, Kelten, Thapa, Alekh, Cowell, Anna, Conway, David ORCID: https://orcid.org/0000-0001-7762-4063, Douglas, Catriona M. and Paterson, Claire
(2024)
Impact of the COVID-19 pandemic on stage and incidence of head and neck cancer: a rapid review and meta-analysis.
Clinical Otolaryngology, 49(4),
pp. 363-375.
(doi: 10.1111/coa.14152)
(PMID:38514776)
Thapa, A. et al. (2024) The UK Divide: Does having a Pembrolizumab-Chemotherapy option in head and neck cancer matter? Real-world experience of first-line palliative pembrolizumab monotherapy and pembrolizumab-chemotherapy combination in Scotland. Clinical Oncology, 36(5), pp. 287-299. (doi: 10.1016/j.clon.2024.02.004) (PMID:38395634)
Clements, Kelten, Cowell, Anna, White, Gillian, Flynn, Willian, Conway, David I. ORCID: https://orcid.org/0000-0001-7762-4063, Douglas, Catriona M. and Paterson, Claire
(2023)
The COVID-19 pandemic has not changed stage at presentation nor treatment patterns of head and neck cancer: a retrospective cohort study.
Clinical Otolaryngology, 48(4),
pp. 587-594.
(doi: 10.1111/coa.14048)
(PMID:36929626)
Hay, Lisa K., McLoone, Philip ORCID: https://orcid.org/0000-0003-0002-8700, Borgaonkar, Saurabh, Schipani, Stefano, Wilson, Christina, Grose, Derek, James, Allan
ORCID: https://orcid.org/0000-0003-4472-7095, Lamb, Carolynn and Paterson, Claire
(2023)
Can elderly patients be safely selected for head and neck radiotherapy without formal geriatric or frailty assessment: a retrospective cohort study.
Clinical Otolaryngology, 48(2),
pp. 240-244.
(doi: 10.1111/coa.14005)
(PMID:36366954)
Poon, Wai-Yan, Paterson, Claire, McLoone, Philip ORCID: https://orcid.org/0000-0003-0002-8700, Grose, Derek, Schipani, Stefano, Lamb, Carolynn, James, Allan
ORCID: https://orcid.org/0000-0003-4472-7095 and Wilson, Christina
(2023)
Survival outcomes in hypopharyngeal cancer in the West of Scotland Cancer Network.
Clinical Otolaryngology, 48(2),
pp. 235-239.
(doi: 10.1111/coa.14003)
(PMID:36344424)
Creaney, Grant ORCID: https://orcid.org/0000-0001-9972-7629, McMahon, Alex D.
ORCID: https://orcid.org/0000-0002-9425-7792, Ross, Alastair J.
ORCID: https://orcid.org/0000-0003-2952-3182, Bhatti, Lesley A., Paterson, Claire and Conway, David I.
ORCID: https://orcid.org/0000-0001-7762-4063
(2022)
Head and neck cancer in the UK: what was the stage before COVID-19? UK cancer registries analysis (2011-2018).
British Dental Journal, 233(9),
pp. 787-793.
(doi: 10.1038/s41415-022-5151-4)
(PMID:36369569)
(PMCID:PMC9650177)
Zhou, S. et al. (2022) Long term survival in patients with human papillomavirus-positive oropharyngeal cancer and equivocal response on 12-week PET-CT is not compromised by the omission of neck dissection. Oral Oncology, 128, 105870. (doi: 10.1016/j.oraloncology.2022.105870) (PMID:35447564)
Grocutt, Laura, Paterson, Claire and Valentine, Ronan M. (2022) Adaptive dose escalated radiotherapy in oropharyngeal cancers: a treatment planning feasibility study. Radiation Oncology, 17, 24. (doi: 10.1186/s13014-022-01991-x) (PMID:35123516) (PMCID:PMC8817487)
Poon, W.-Y. et al. (2020) Comparative cohort study of volumetric modulated arc therapy for squamous cell cancer of unknown primary in the head and neck-involved neck only versus mucosal irradiation. Clinical Otolaryngology, 45(6), pp. 847-852. (doi: 10.1111/coa.13593) (PMID:32501648)
Hay, L. K. et al. (2020) Analysis of dose using CBCT and synthetic CT during head and neck radiotherapy: A single centre feasibility study. Technical Innovations and Patient Support in Radiation Oncology, 14, pp. 21-29. (doi: 10.1016/j.tipsro.2020.02.004) (PMID:32226833) (PMCID:PMC7093804)
Paterson, C. et al. (2019) Radiotherapy-induced xerostomia: a randomised, double-blind, controlled trial of Visco-ease™ oral spray compared with placebo in patients with cancer of the head and neck. British Journal of Oral and Maxillofacial Surgery, 57(10), pp. 1119-1125. (doi: 10.1016/j.bjoms.2019.10.300) (PMID:31672256)
Grants
Grants and Awards listed are those received whilst working with the University of Glasgow.
- Predicting and investigating radiotherapy resistance in poor prognosis head and neck squamous cell cancer
Edinburgh Cancer Research Centre
2022 - 2025
- Predicting radiotherapy (RT) response using circulating metabolites
Cancer Research UK
2021 - 2022
- Deciphering the molecular landscape of radiotherapy resistance in patients with high risk HNSCC
Cancer Research UK
2021 - 2022